AstraZeneca's LYNPARZA (olaparib) will be funded for ovarian cancer in New Zealand - three years after the company submitted an application to PHARMAC. …
Latest Video
New Stories
-
New TGA approvals for UCB's interleukin inhibitor
May 8, 2024 - - Latest News -
Home Affairs Minister reveals the facts on the independence of advisory committees
May 8, 2024 - - BioPharma -
AusBiotech policy leader appointed to lead BioMelbourne Network
May 8, 2024 - - BioPharma -
Momentum Clinical Research recruiting for Australian-based clinical trials
May 7, 2024 - - Australian Biotech -
TGA seeks nominations for statutory advisory committees
May 7, 2024 - - Latest News -
No timeline from the minister on HTA Review report release and response
May 7, 2024 - - Latest News -
The PBAC chair appointment took effect when it did, because it had to
May 7, 2024 - - Latest News